Role of macrophages in hemangioendothelioma development
Role of macrophages in hemangioendothelioma development
批准号:
6875770
负责人:
Gayle M Gordillo
金额:
$12.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Hemangiomas represent the most common soft tissue tumor in children and hemangioendothelioma (HE) are a clinical subtype. Proliferating HE are associated with macrophage infiltration and MCP-1 expression. Macrophages seen in proliferating neoplasms, such as those seen in HE are referred to as tumor associated macrophages (TAM) and their biological role has not been defined. It is hypothesized that TAM facilitate angiogenesis to support HE development. Macrophages possess NADPH oxidase that generates substantial amounts of inducible reactive oxygen species (ROS), which are now recognized as key signaling mediators. Specifically, ROS have been described to be a key player in facilitating the expression of angiogenic factor and neovascularization as well. Therefore, it is possible that macrophage-derived ROS may drive hemangioendothelioma development. In the proposed study, the candidate will test the hypothesis that MCP-1 recruited TAM and its ROS derivative play a critical role in promoting angiogenesis and hemangioendothelioma (HE) development. In vivo and in vitro experiments will be conducted using a murine model of HE and culture EOMA cells, respectively. The proposal rests on a striking finding that MCP-1 and NADPH oxidase are key contributors to HE development. These results were derived from the use of appropriate knock-out animal models.
To test the stated hypothesis, the following three specific aims will be addressed: Aim #1: Determine the significance of macrophages in HE development. Aim #2: Characterize in vitro whether macrophage-derived ROS influences the angiogenic characteristics behavior of EOMA cells and whether H202 is the primary signaling molecule mediating the effect of ROS; and Aim #3: Test in vivo the significance of macrophage-derived ROS on HE development.
The long-term goal is to develop a research career in the field of clinically relevant angiogenesis and underlying mechanisms. The current proposal includes didactic and research training elements towards the development of a surgical scientist career of a hispanic woman plastic surgeon.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FIrst REsponse BUrn Diagnostic System (FIRE-BUDS)
-
批准号:10392084
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2022
-
负责人:Gayle M Gordillo
-
依托单位:
FIrst REsponse BUrn Diagnostic System (FIRE-BUDS)
-
批准号:10581541
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2022
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Ulcer Clinical Research Unit
-
批准号:10450904
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2021
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Ulcer Clinical Research Unit
-
批准号:9980414
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Ulcer Clinical Research Unit
-
批准号:10615582
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Consortium Clinical Research Unit
-
批准号:10685135
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Consortium Clinical Research Unit
-
批准号:10892442
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Ulcer Clinical Research Unit
-
批准号:10201585
-
项目类别:
-
资助金额:$55.13万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Consortium Clinical Research Unit
-
批准号:10916733
-
项目类别:
-
资助金额:$21.14万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Diabetic Foot Ulcer Clinical Research Unit
-
批准号:9788432
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2018
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms Regulating Hemangioendothelioma: A Plastic Surgeon's Challenge
-
批准号:8606469
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms regulating hemangioendothelioma: A plastic surgeon's challenge
-
批准号:9751313
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms regulating hemangioendothelioma: A plastic surgeon's challenge
-
批准号:9390625
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms Regulating Hemangioendothelioma: A Plastic Surgeon's Challenge
-
批准号:8026082
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms Regulating Hemangioendothelioma: A Plastic Surgeon's Challenge
-
批准号:8417020
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms regulating hemangioendothelioma: A plastic surgeon's challenge
-
批准号:10012938
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Mechanisms Regulating Hemangioendothelioma: A Plastic Surgeon's Challenge
-
批准号:8215711
-
项目类别:
-
资助金额:$30.19万
-
财政年份:2011
-
负责人:Gayle M Gordillo
-
依托单位:
Role of macrophages in hemangioendothelioma development
-
批准号:7211491
-
项目类别:
-
资助金额:$12.73万
-
财政年份:2004
-
负责人:Gayle M Gordillo
-
依托单位:
Role of macrophages in hemangioendothelioma development
-
批准号:6777280
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2004
-
负责人:Gayle M Gordillo
-
依托单位:
Role of macrophages in hemangioendothelioma development
-
批准号:7391825
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2004
-
负责人:Gayle M Gordillo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: